Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

TADAWUL:4015 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	137.46	261.67	284.28	141.18	112.63	235.55
Short-Term Investments	0.61	0.69	0.8	1.06	39.36	20.53
Trading Asset Securities	-	0.64	5.16	5.12	-	-
Cash & Short-Term Investments	138.07	263	290.24	147.36	151.99	256.08
Cash Growth	-35.96%	-9.38%	96.96%	-3.05%	-40.65%	27.55%
Accounts Receivable	707.11	443.52	332.13	352.36	366.9	418.22
Other Receivables	-	29.77	22.68	28.59	20.58	18.02
Receivables	707.11	473.29	360.62	389.27	404.93	454.72
Inventory	245.76	270.88	233.92	131.86	135.17	129.2
Prepaid Expenses	-	4.57	3.99	4.52	3.09	2.54
Other Current Assets	59.54	16.95	17.93	15.08	4.48	4.17
Total Current Assets	1,150	1,029	906.7	688.08	699.67	846.71
Property, Plant & Equipment	677.81	673.93	698.3	705.05	713.87	613.56
Long-Term Investments	62.2	57.49	36.11	0.25	3.97	3.83
Other Intangible Assets	14.04	11.53	13.05	14.43	14.79	16.54
Other Long-Term Assets	-	-	-	-	-	15.02
Total Assets	1,905	1,772	1,654	1,408	1,432	1,496
Accounts Payable	233.04	42.61	67.98	39.79	41.81	41.9
Accrued Expenses	-	104.19	66.75	51.98	59.55	46.15
Current Portion of Long-Term Debt	-	-	-	-	-	95.02
Current Portion of Leases	0.27	0.26	0.25	0.24	0.25	0.26
Current Income Taxes Payable	35.58	28.8	25.51	17.72	19.74	20.59
Current Unearned Revenue	-	2.14	3.77	-	-	-
Other Current Liabilities	-	23.76	15.72	17.27	17.01	35.15
Total Current Liabilities	268.89	201.76	179.97	126.99	138.36	239.07
Long-Term Leases	2.15	1.83	2.16	2.4	1.72	1.97
Total Liabilities	358.02	281.03	249.84	191.55	200.66	316.59
Common Stock	700	700	700	700	100	100
Retained Earnings	1,006	950.81	811.99	591.35	1,170	1,113
Comprehensive Income & Other	-159.13	-160.21	-107.66	-75.08	-37.88	-33.73
Total Common Equity	1,547	1,491	1,404	1,216	1,232	1,179
Shareholders' Equity	1,547	1,491	1,404	1,216	1,232	1,179
Total Liabilities & Equity	1,905	1,772	1,654	1,408	1,432	1,496
Total Debt	2.43	2.09	2.4	2.64	1.97	97.24
Net Cash (Debt)	135.64	260.91	287.84	144.72	150.03	158.84
Net Cash Growth	-36.45%	-9.36%	98.89%	-3.53%	-5.55%	-3.45%
Net Cash Per Share	1.94	3.73	4.11	2.07	15.00	15.88
Filing Date Shares Outstanding	70	70	70	70	10	10
Total Common Shares Outstanding	70	70	70	70	10	10
Working Capital	881.59	826.92	726.73	561.09	561.3	607.64
Book Value Per Share	22.09	21.29	20.06	17.38	123.16	117.91
Tangible Book Value	1,532	1,479	1,391	1,202	1,217	1,163
Tangible Book Value Per Share	21.89	21.13	19.88	17.17	121.68	116.25
Land	58.57	58.56	59.73	60.46	62.59	62.58
Buildings	271.59	271.46	224.31	177.98	176.67	153.84
Machinery	722.45	719.15	564.16	515.41	510.48	488.57
Construction In Progress	64.48	59.53	252.89	329.94	325.12	249.46

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.